Dr. Shafi M. Khalid, MD

Dr. Khalid practices at Highly Artistic Surgery, Inc in Poway, California.

Dr. Khalid's NPI, 1750343760, was assigned on April 5, 2006. Dr. Khalid graduated from Mymensingh Medical College in 1982. Dr. Khalid holds California license C51093.

Dr. Khalid's primary practice is Highly Artistic Surgery, Inc, at 15725 Pomerado Rd, Poway, CA 92064 in San Diego County. The practice phone is (858) 487-3742.

Dr. Khalid's primary practice is Highly Artistic Surgery, Inc in Poway, California. Dmand AI also links Dr. Khalid to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khalid practices. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Khalid's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Khalid is board certified in geriatric medicine by the American Board of Internal Medicine. Dmand AI has Dr. Khalid's licenses on file in 4 states: California, Arizona, Texas and Michigan.

Dmand AI lists arthritis, bursitis, carpal tunnel syndrome, drug use disorders, enthesopathy in arms, enthesopathy in foot or ankle, fibromyalgia and chronic pain and fluid in a joint among the conditions Dr. Khalid treats.

CMS data shows 13,610 Medicare services from Dr. Khalid across 21 procedure codes in 2024, for 210 Medicare patients. Medicare paid $412,817 for them. Every service was in an office.

CMS counts 210 Medicare patients who saw Dr. Khalid in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have arthritis, and 73% have high blood pressure. 69% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khalid's median patient age at 63, with 61% women.

In 2024, Dr. Khalid wrote 1,028 Medicare Part D claims for 216 patients. 98% of them were for generic drugs. CMS names the drug for 939 of them, across 18 drugs with 11 or more claims each, at $14,466 in total drug cost. In 2023, CMS named 1,801 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Khalid for performance year 2024, reported individually. Dr. Khalid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khalid as offering telehealth.

CMS Open Payments shows 238 general payments to Dr. Khalid from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Boston Scientific Corporation paid the most, $980.

Dr. Khalid graduated from Mymensingh Medical College in 1982.

Dr. Khalid is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.